A strong company in Asia is not automatically a strong European investment case. The second underwriting tests whether an entirely new institutional version of the business can be built without destroying the economics that made the company attractive.
KUALA LUMPUR | SEPTEMBER 2026
Imagine two investment committee papers on the same business.
The first describes a well-run Asian growth company with repeat customers, credible unit economics and a management team that knows its home market intimately. It passes. The second describes the European company that management intends to create from it: a different sales cycle, a different cost to serve, unfamiliar procurement rules, new regulatory exposure, a partially rebuilt leadership team and cash tied up for longer than the original model assumed. It fails.
There is no contradiction. There are two businesses in the room, and only one of them exists.
That is the premise of the second underwriting. Conventional diligence asks whether a company is attractive as it stands. Cross-border growth capital must ask a harder question: can the institutional version required for Europe be built, at an acceptable cost, before the expansion thesis consumes the margin, attention and time on which the original valuation depends?
The distinction matters because Asia-Europe activity is hardly a blank space. The European Commission describes ASEAN as a market of roughly 660 million consumers and the European Union’s third-largest trading partner outside Europe. In 2025, goods trade between the two reached EUR 274.9 billion. Capital also moves in both directions: in 2024, ASEAN investment stock in the EU stood at EUR 294.1 billion.
The opportunity, therefore, is not the discovery of a corridor. It is the more exacting work of measuring what happens to a company while it crosses one. Country risk describes the environment a business enters. Conversion risk describes the choices required to make that business function there. The first can be observed from a distance; the second must be built into the investment case.
UNDERWRITING THE COMPANY THAT MUST EXIST
The first underwriting is familiar. It tests product utility, customer concentration, revenue quality, cash conversion, competitive position, management credibility and the price paid for risk. It asks whether the current business deserves capital.
The second underwriting begins where that analysis usually ends. It treats European expansion neither as a line in a growth plan nor as an automatic valuation uplift. It treats it as the construction of a new operating system.
Commercial portability comes first. A product may solve the same underlying problem in Kuala Lumpur, Jakarta or Bangkok and still meet a different buying logic in Frankfurt or Paris. Who owns the budget? Which proof points survive the journey? Can an Asian reference customer carry weight with a European procurement committee, or must credibility be rebuilt account by account? A market-size slide answers none of these questions.
Institutional portability is a separate test.The company may need new data controls, audit practices, contractual standards, product documentation, board discipline or regulatory capability before a serious European customer will accept it. These are not administrative details to be addressed after entry. They determine entry.
Then comes economic portability.The home-market gross margin can be misleading once channel economics, local service, compliance, taxation, implementation effort and longer collection cycles enter the model. A credible case rebuilds unit economics from the European customer’s purchase process backward. It does not merely apply a regional revenue multiple to management’s ambition.
Finally, there is organisational portability. Does the existing team have the bandwidth to protect its core business while creating another? Which decisions remain at headquarters, and which require genuine local authority? Is the proposed partner a route to market or a single point of dependency? Can management recruit people capable of challenging the assumptions on which the expansion was sold?
These tests produce a conversion ledger: each critical assumption, the evidence supporting it, the person responsible for resolving it, the capital and time required, and the fact that would invalidate it. That ledger is more useful than an enthusiastic market-entry narrative because it makes uncertainty governable.
THE OPTION SHOULD NOT BE VALUED AS AN ACCOMPLISHED FACT
The second underwriting also changes valuation discipline. The existing company and the European expansion option should not be collapsed into one forecast simply because they appear in the same spreadsheet. The base business has evidence. The expansion has hypotheses.
An investment committee can therefore separate the value of what already works from the value that may be created through conversion. A disciplined paper carries at least three distinct views: the value of the business without Europe, the capital required before conversion evidence exists, and the value contingent on named proof points. It avoids paying today for upside whose creation will require more capital tomorrow.
Conviction can then be staged around evidence such as regulatory readiness, a referenceable first customer, acceptable local unit economics, independent governance and a management structure that no longer relies on heroic attention from the founder. Until those facts exist, the option remains an option.
Governance rights must also match the value-creation claim. If the thesis depends on changes to controls, leadership, pricing or route to market, the investor needs information rights and intervention mechanisms proportionate to that work. An active conversion thesis paired with passive visibility is an avoidable mismatch.
This is especially important in Europe, where even locally established scale-ups encounter structural financing and market constraints. The European Investment Bank’s research on the scale-up gap links financial constraints to relocation and exit outcomes among innovative EU firms. An incoming Asian company faces those conditions in addition to the liability of being unfamiliar.
The same reasoning applies at portfolio level. A collection of companies can look diversified by sector while carrying the same hidden exposure: delayed regulatory clearance, dependence on a small group of distributors, weak local governance or a longer-than-modelled path to customer trust. Conversion risk can be correlated even when products are not. Pacing, reserves and concentration limits should reflect that reality.
The most persuasive sign of discipline is the willingness to reject European expansion for an otherwise attractive company. A second-underwriting failure is not a verdict on the founder or the home-market business. It may mean the timing is wrong, the institutional burden is uneconomic, or another geography offers a better path. Capital should not be asked to rescue a strategic ambition from evidence.
A CORRIDOR ADVANTAGE MUST APPEAR IN THE PROCESS
This is the thesis being developed through Pure Pulse, a founder-led private-capital platform in formation. Dr. A.J. Minai’s advantage is rooted in an Asia-native operating and relationship base, combined with an ability to interpret companies for European institutional settings. Yet biography alone is not an investment process, and access alone is not an edge.
For the corridor advantage to be real, it must appear in sourcing records, reference quality, screening rules, the conversion ledger and the decisions an investment committee is prepared not to make. It must also sit within a clear management architecture. Thesis origination, relationship access and corridor execution are distinct from authorised management, fiduciary oversight, risk, compliance, valuation and formal investment authority. Sophisticated sponsorship does not blur those roles; it makes them explicit.
That separation is strategically useful. It allows an originator to contribute differentiated judgment without asking the market to suspend institutional standards. It also protects a future vehicle from becoming a proxy for one person’s network. The process should be able to explain why a company belongs in the corridor, what must change, who owns each transition and what evidence would cause the committee to stop.
Pure Pulse is not underwriting Asian growth in the abstract. It is underwriting whether Asian growth can survive institutional translation.
That is a narrower claim than the familiar promise of access to a dynamic region. It is also a more demanding one. Geography does not create the investment case. The ability to identify, price and govern conversion risk does.
